Showing results (211-220 of 586) with videos related to
Sort By:
Pageof 59
Journal of the American College of Cardiology|December 6, 2008
Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivoDavid Erlinge, Christoph Varenhorst, Oscar O Braun, et al.The American Journal of Cardiology|February 22, 2020
Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or TicagrelorMichelle T Sun, Sonia Huang, Stephen D Wiviott, et al.JAMA|February 18, 2015
Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarctionKarolina Szummer, Jonas Oldgren, Lars Lindhagen, et al.European Heart Journal|April 26, 2003
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus studyLars Wallentin, Lott Bergstrand, Mikael Dellborg, et al.The American Journal of Cardiology|January 31, 2006
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)Stefan K James, Bertil Lindahl, Jorik R Timmer, et al.Heart (British Cardiac Society)|November 11, 2015
Dabigatran etexilate and reduction in serum apolipoprotein BPhilip Joseph, Guillaume Pare, Lars Wallentin, et al.Thrombosis and Haemostasis|October 9, 2008
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery diseaseOscar O Braun, Matilda Johnell, Christoph Varenhorst, et al.Clinical Journal of the American Society of Nephrology : CJASN|May 9, 2009
Early angiography in patients with chronic kidney disease: a collaborative systematic reviewDavid M Charytan, Lars Wallentin, Bo Lagerqvist, et al.Journal of the American College of Cardiology|October 1, 2013
The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)Paul A Reilly, Thorsten Lehr, Sebastian Haertter, et al.Journal of the American Heart Association|March 23, 2019
Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart DiseaseRalph A H Stewart, Claes Held, Sue Krug-Gourley, et al.Pageof 59